Cyp11A1 Protein (Cholesterol Side Chain Cleavage Enzyme) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Structure
CYP11A1 is a mitochondrial cytochrome P450 enzyme that catalyzes the first and rate-limiting step of steroidogenesis: the cleavage of the side chain of cholesterol to produce pregnenolone. In the brain, this enzyme is involved in neurosteroid synthesis, which modulates GABA-A and [NMDA](/entities/nmda-receptor) receptor function.
The protein contains characteristic domains relevant to its function:
transmembrane domains for membrane localization
functional domains specific to its protein family
potential regulatory regions
Normal Function
Cellular Roles
Membrane protein targeting and insertion
Protein quality control mechanisms
Lipid metabolism and homeostasis
Cellular stress response pathways
Brain Expression
This protein is expressed in various brain regions:
Cerebral [cortex](/brain-regions/cortex) ([neurons](/entities/neurons) and glia)
[Hippocampus](/brain-regions/hippocampus)
Basal ganglia
[Cerebellum](/brain-regions/cerebellum)
Role in Disease
Alzheimer's Disease
Alzheimer's Disease is associated with altered CHASER (CYP11A1) function through genetic variants and expression changes.
Disease Mechanisms
Altered protein localization or trafficking
Impaired cellular quality control
Dysregulated lipid or ion homeostasis
Therapeutic Targeting
Current Approaches
Research is ongoing to develop therapeutic strategies:
The study of Cyp11A1 Protein (Cholesterol Side Chain Cleavage Enzyme) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Enzymatic Mechanism
CYP11A1 (Cytochrome P450 11A1), also known as P450scc (side-chain cleavage), is a mitochondrial cytochrome P450 enzyme that catalyzes the first and rate-limiting step in steroid hormone biosynthesis. This enzyme converts cholesterol to pregnenolone through a three-step process.
Catalytic Reaction
The reaction proceeds through three sequential monooxygenation steps:
Each step requires:
2 NADPH
3 O₂ molecules
Adrenodoxin (elec- Adrenodoxin reductase
Structural Features
Enzyme Architecture
Structural Studies
Crystal structures available (PDB: 3N9Y, 3NA1) show:
Typical P450 fold with 12 α-helices
Substrate access channel on proximal face
Membrane insertion via N-terminal helix
Neurosteroid Production in Brain
Local Steroidogenesis
The brain synthesizes steroids de novo (neurosteroids):
Pregnenolone: First neurosteroid, precursor to all others